Arno Therapeutics, Inc.

Arno Therapeutics, Inc.

Sector: Pharmaceutical Preparations Region: NJ, United States

: | OTC Markets: ARNI

Similar to: AstraZeneca Plc, Mast Therapeutics, Inc., Skystar Bio-Pharmaceutical Co.

Arno Therapeutics, Inc. operates as a development stage company, which focuses on developing innovative products for the treatment of cancer. The company has worldwide rights to develop and market three innovative clinical-stage anti-cancer product candidates with mechanisms of action. The compounds are in clinical testing as potential best- or first-in-class products to treat hematologic malignancies and solid tumors. Arno Therapeutics was founded by Peter Morgan Kash, Tanen M. David and Joshua A. Kazam in March 2000 and is headquartered in Flemington, NJ.

News & Analysis

You may also be interested in: